| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vistagen Therapeutics, Inc. | Chief Operating Officer | Common Stock | 10.9K | $18.5K | $1.70 | Jun 30, 2025 | Direct |
| Vistagen Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 100K | Jun 23, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | Jun 30, 2025 | 1 | $8.3K | 4 | Jul 1, 2025 | Chief Operating Officer |
| VTGN | Vistagen Therapeutics, Inc. | Jun 23, 2025 | 1 | $0 | 4 | Jun 25, 2025 | Chief Operating Officer |
| VTGN | Vistagen Therapeutics, Inc. | Dec 31, 2024 | 1 | $8.3K | 4 | Jan 13, 2025 | Chief Operating Officer |
| VTGN | Vistagen Therapeutics, Inc. | Jun 28, 2024 | 1 | $7.9K | 4 | Jul 2, 2024 | Chief Operating Officer |
| VTGN | Vistagen Therapeutics, Inc. | Jun 24, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Chief Operating Officer |
| VTGN | Vistagen Therapeutics, Inc. | Oct 24, 2023 | 0 | $0 | 3 | Nov 3, 2023 | Chief Operating Officer |